Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Zinc finger-containing ubiquitin peptidase 1 (ZUP1) is a protein-coding enzyme characterized by zinc finger motifs and a cysteine peptidase domain. ZUP1 acts as a K63-specific deubiquitinating enzyme, primarily catalyzing the cleavage of long K63-linked polyubiquitin chains internally rather than removing ubiquitin from the chain ends. This enzymatic activity is important for the regulation of DNA repair, maintenance of genome stability, and proper cellular response to DNA damage. ZUP1 is closely related to, but distinct from, proteases for other ubiquitin-like modifiers such as Ufm1. Recent research also implicates ZUP1 in the regulation of antiviral immunity by amplifying MAVS-mediated signaling in response to viral RNA. Loss or dysfunction of ZUP1 may contribute to disease phenotypes characterized by impaired DNA repair and immune dysregulation, including some cancers and autoinflammatory conditions. References: [1][3][4][5][6][2]
Deubiquitination of specific ubiquitin chain linkages (K63-linked polyubiquitin), modulates DNA repair processes, antiviral innate immune amplification via MAVS complex
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger-containing ubiquitin peptidase 1 (ZUP1).